Your browser doesn't support javascript.
loading
Strengths and weaknesses of the Brazilian regulation on biosimilars: A critical view of the regulatory requirements for biosimilars in Brazil.
de Assis, Marcos Renato; Pinto, Valdair.
Affiliation
  • de Assis MR; Famema - Marília Medical School, R. Monte Carmelo, 800 - Fragata, Marília SP 17519-030, Brazil.
  • Pinto V; Okrafields Medicina Farmacêutica Ltda., São Paulo, SP, Brazil.
Ther Adv Musculoskelet Dis ; 10(12): 253-259, 2018 Dec.
Article in En | MEDLINE | ID: mdl-30515251
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Ther Adv Musculoskelet Dis Year: 2018 Document type: Article Affiliation country: Brasil Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies Country/Region as subject: America do sul / Brasil Language: En Journal: Ther Adv Musculoskelet Dis Year: 2018 Document type: Article Affiliation country: Brasil Country of publication: Reino Unido